APC Presentation (PPT)
VAXINNATE in NEWS
Vaccines Europe 2010
Join us for 2010's Vaccines Europe, set to be Informa's best yet!
Influenza Congress USA – Washington DC
Commercial development and investment opportunities in influenza vaccines and antivirals
Top 10 Most interesting Infectious Diseases Projects to Watch;
Dr. Becker Presented – Received award
Hong Kong SAR
Options for the Control of Influenza VII;
More than 1,400 Researchers from all corners of the globe convened in Hong Kong, SAR, China for Options for the Control of Influenza VII.
VaxInnate in News
VaxInnate Awarded U.S. Government Grant to Develop Dengue Vaccine
Mosuito-borne disease identified as emerging
VaxInnate's License Agreement with Emergent BioSolutions
Improves U.S. Preparedness for Potential Flu Pandemics
Two New Executives Join VaxInnate Management Team
VaxInnate Corporation today announced
Lt. Governor Kim Guadagno Visits VaxInnate
The Christie Administration has made it a priority to
Wayne F. Pisano Joins VaxInnate as CEO
He is the former President and CEO of sanofi pasteur.
VaxInnate Licenses Recombinant Flu Vaccines
To CJ CheilJedang Corporation of South Korea.
U.S. Congressman Rush Holt Visits VaxInnate
Lauds Government Funding for Development of Modern Flu Vaccines.
VaxInnate Awarded Contract by the U.S. Government
Potential value of contract as high as $196 million
HHS awards contracts to develop new flu vaccine technology- VaxInnate
VaxInnate received a HHS contract for the development
©2012 VaxInnate, Inc. |